| Literature DB >> 35116034 |
Zihao He1, Yunqi Zhong1, Danqing Hou1, Xianye Hu1, Zhibin Fu1, Luyao Liu1, Shuang Zhang1,2, Chengbo Sun1,3,4.
Abstract
The intestine is not only an important digestive organ but also an important immune organ for shrimp; it plays a key role in maintaining homeostasis. Decapod iridescent virus 1 (DIV1) is a new type of shrimp-lethal virus that has received extensive attention in recent years. To date, most studies of the shrimp intestinal immune response under viral infections have relied on single omics analyses; there is a lack of systematic multi-omics research. In the current study, intestinal mRNA-seq and microRNA (miRNA)-seq analyses of Marsupenaeus japonicus under DIV1 infection were performed. A total of 1,976 differentially expressed genes (DEGs) and 32 differentially expressed miRNAs (DEMs) were identified. Among them, 21 DEMs were negatively correlated with 194 DEGs from a total of 223 correlations. Functional annotation analysis revealed that M. japonicus can regulate glycosaminoglycan biosynthesis (chondroitin sulfate, dermatan sulfate, and keratan sulfate), vitamin metabolism (retinol metabolism and ascorbate and aldarate metabolism), immune pathway activation (Toll and IMD signaling pathways, Wnt signaling pathway, IL-17 signaling pathway, and Hippo signaling pathway), immunity enzyme activity promotion (triose-phosphate isomerase), antimicrobial peptide (AMP) expression, reactive oxygen species (ROS) production, and cell apoptosis through miRNAs to participate in the host's antiviral immune response, while DIV1 can influence Warburg effect-related pathways (pyruvate metabolism, glycolysis/gluconeogenesis, and citrate cycle), glycosphingolipid biosynthesis-related pathways (glycosphingolipid biosynthesis-globo and isoglobo series and glycosphingolipid biosynthesis-lacto and neolacto series), and the tight junction and adhesion junction of the intestinal mucosal epithelium through the host's miRNAs and mRNA to promote its own invasion and replication. These results indicate that intestinal miRNAs play important roles in the shrimp immune response against DIV1 infection. This study provides a basis for further study of the shrimp intestinal antiviral immune response and for the formulation of effective new strategies for the prevention and treatment of DIV1 infection.Entities:
Keywords: Marsupenaeus japonicus; decapod iridescent virus 1; intestinal immune response; mRNA; miRNA
Mesh:
Substances:
Year: 2022 PMID: 35116034 PMCID: PMC8804360 DOI: 10.3389/fimmu.2021.807093
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Details of the primer sequence used for qRT-PCR.
| No. | Primer Names | Sequences (5′–3′) |
|---|---|---|
|
| ||
| 1 | Unigene15935_All-F | TCTGACCGCTGAGAACTTTG |
| 2 | Unigene15935_All-R | TCTACGAGCTAGAGCTGATGTG |
| 3 | CL1405.Contig4_All-F | TTCTGGCTGCTGTAAGAGTGA |
| 4 | CL1405.Contig4_All-R | TTGCTGGAGTGGTACGTGAT |
| 5 | CL3214.Contig2_All-F | CCCTGATTTCCCTTGCTTC |
| 6 | CL3214.Contig2_All-R | TCTTCCTCTTTGCCGTCCT |
| 7 | CL1030.Contig_All4-F | TTTGCCCGTGACTTTGTTC |
| 8 | CL1030.Contig4_All-R | CAGTTCGGATTTCCCCTCT |
| 9 | Unigene10378_All-F | AACATCATCCCTTGAACCCG |
| 10 | Unigene10378_All-R | CGCTGTCTTTTGCTTCGTTG |
| 11 | CL2943.Contig2_All-F | AGAATCCTATCCCCTCGGTA |
| 12 | CL2943.Contig2_All-R | TGCTCATACTTGTGATGTCGC |
| 13 | CL3345.Contig1_All-F | GCAATGTCGTGGATAAGCG |
| 14 | CL3345.Contig1_All-R | AAGCAGGGAGGCAATGAGT |
| 15 | CL2966.Contig1_All-F | CGCCCATTTCTTCGTTTC |
| 16 | CL2966.Contig1_All-R | TGTGCTGCCATGTCGTTAA |
| 17 | CL2784.Contig5_All-F | TCTACTTCGTCAAGGTGGGC |
| 18 | CL2784.Contig5_All-R | TCCGTCGTCATCCGTATCTC |
| 19 | CL709.Contig1_All-F | TTTGTCTTGCTGCCTTCCTA |
| 20 | CL709.Contig1_All-R | GAGTCCTGTGGTGGTTTTGAG |
| 21 | CL2520.Contig2_All-F | TCATCCACCGTTTTCTACCC |
| 22 | CL2520.Contig2_All-R | CTTGATTACATTGCCCTTGC |
| 23 | Unigene18060_All-F | CAGCAGAGTTTTCCCCACA |
| 24 | Unigene18060_All-R | TATTTCGAGACGGCAGAGC |
| 25 | CL3472.Contig2_All-F | GCTGAACCTGCTGGAATGA |
| 26 | CL3472.Contig2_All-R | TGGAGACTGCTGTCCCTTGT |
| 27 | CL1127.Contig3_All-F | CCAGGCTACAAAGTGGAGTG |
| 28 | CL1127.Contig3_All-R | GTCTTGGCAACATTGGTGAA |
| 29 | CL2402.Contig3_All-F | CACCAACGGAAAGACCTACTC |
| 30 | CL2402.Contig3_All-R | AGACCGCTGCCTTGAAATA |
| 31 | MjEF1-α-F | GGAACTGGAGGCAGGACC |
| 32 | MjEF1-α-R | AGCCACCGTTTGCTTCAT |
|
| ||
| 33 | miR-193-3p_6-F | TACTGGCCTGCTAAGTCCCAA |
| 34 | miR-263b-F | CTTGGCACTGGAAGAATTCACAGA |
| 35 | miR-6493-5p-F | ACGTCCGGCAGGTTTTACC |
| 36 | novel_mir86-F | TATATATATATAGCGCGCGGGCGG |
| 37 | miR-263a-5p_1 | AATGGCACTGGAAGAATTCACGG |
| 38 | novel_mir56 | TATATATATAGGCGGGGGCTGGC |
| 39 | miR-750_3-F | CGCAGATCTAACTCTTCCAGCTCA |
| 40 | novel_mir63-F | TATATATACGCGTGGGGGATGACG |
| 41 | novel_mir82-F | TATATAGCGCGGCCGGATG |
| 42 | novel_mir40-F | ACGCCTTTGGTTTTACGGTCTTC |
| 43 | novel_mir58 | TCTCTGCGGCTCTTGGC |
| 44 | U6-F | CGCAAGGATGACACGCAAATT |
| 45 | Reverse Primer | Universal PCR Primer R (Sangon Biotech) |
Summary of mRNA-seq data.
| Samples | Raw Reads Number | Clean Reads Number | Clean Bases (Gb) | Q20 (%) | Q30 (%) | Clean Reads Ratio (%) | GC (%) |
|---|---|---|---|---|---|---|---|
| DIV1-1 | 43,821,050 | 42,839,474 | 6.43 | 96.62 | 91.58 | 97.76 | 43.06 |
| DIV1-2 | 43,821,050 | 42,765,910 | 6.41 | 96.85 | 92.09 | 97.59 | 42.65 |
| DIV1-3 | 43,821,050 | 42,930,064 | 6.44 | 97.00 | 92.40 | 97.97 | 41.98 |
| Control-1 | 43,821,050 | 43,144,600 | 6.47 | 96.60 | 91.45 | 98.46 | 42.92 |
| Control-2 | 43,821,050 | 42,908,058 | 6.44 | 96.68 | 91.75 | 97.92 | 43.10 |
| Control-3 | 43,821,050 | 42,883,528 | 6.43 | 96.81 | 92.02 | 97.86 | 43.15 |
| Total | 306,747,350 | 300,355,162 | 45.05 | 96.79 | 91.95 | 97.89 | 42.98 |
GC, guanine–cytosine.
Figure 1Length distribution and annotation of transcriptome unigenes. (A) Length distribution of transcriptome unigenes. The x-axis indicates the length of unigenes, and the y-axis indicates the number of unigenes. (B) Annotation of transcriptome unigenes. The Venn diagram shows the annotation of unigenes from the Marsupenaeus japonicus transcriptome in 6 databases, including the KEGG, GO, KOG, Nr, Pfam, and SwissProt databases. KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, Gene Ontology.
Figure 2Sequence analysis and functional annotation of assembled unigenes identified from the Marsupenaeus japonicus intestine under DIV1 infection. (A) Species distribution of the BLASTx matches of the transcriptome unigenes. This figure shows the species distribution of unigene BLASTx matches against the Nr protein database and the proportions for each species. (B) GO terms (level 2) and annotation of the integrated transcriptome assembly. The x-axis indicates 3 GO categories with 41 subcategories, and the y-axis indicates the number of unigenes. (C) KOG function classification of unigenes. Each bar represents the number of unigenes classified into each of the 25 KOG functional categories. The x-axis represents the functional categories, and the y-axis represents the frequency. (D) KEGG biological pathway classification histograms for annotated unigenes. Each bar represents the number of unigenes classified into different biological processes. The x-axis shows the number of the matched unigenes, and the y-axis shows the pathways from the KEGG classification. DIV1, decapod iridescent virus 1; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.
Figure 3M-versus-A plot (MA plot) between DEGs of the DIV1-infected and negative control Marsupenaeus japonicus intestines. The x-axis indicates the average expression level, and the y-axis indicates the fold change. Red dots represent the significantly upregulated DEGs, while blue dots represent the significantly downregulated DEGs (Q-value < 0.05 and |log2(fold change)| > 1). Gray dots represent the DEGs that were not significantly different. DEGs, differentially expressed genes; DIV1, decapod iridescent virus 1.
Figure 4GO term and KEGG pathway enrichment analyses of DEGs. (A) GO bubble plot showing a summary of the top 20 enriched GO terms (level 3). Different colors represent different GO categories, including biological process, cellular component, and molecular function. The x-axis indicates up–down normalization, and the y-axis indicates −log10(p-value). (B) The first lap indicates the top 20 KEGG pathways (level 3), and the number of genes corresponds to the outer lap. The second lap indicates the number of genes in the genome background and the Q-values for the enrichment of the DEGs for the specified biological process. The third lap indicates the ratio of the upregulated genes (deep purple) and downregulated genes (light purple). The fourth lap indicates the enrichment factor of each KEGG term. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes.
Summary of miRNA-seq data.
| Samples | Raw Tags Count | Clean Tags Count | Q20 (%) | Clean Tags Ratio (%) |
|---|---|---|---|---|
| DIV1-1 | 28,881,041 | 27,192,640 | 98.00 | 94.15 |
| DIV1-2 | 27,944,852 | 26,544,371 | 97.70 | 94.99 |
| DIV1-3 | 29,744,908 | 28,022,192 | 98.30 | 94.21 |
| Control-1 | 21,529,313 | 20,219,118 | 98.00 | 93.91 |
| Control-2 | 28,632,772 | 26,716,074 | 97.90 | 93.31 |
| Control-3 | 28,918,111 | 27,255,534 | 97.80 | 94.25 |
| Total | 165,650,997 | 155,949,929 | 97.95 | 94.14 |
Figure 5Length distribution, abundance, and composition of small RNA libraries of DIV1-infected and non-infected Marsupenaeus japonicus intestine. (A) Length distribution and abundance of small RNAs from the intestine of the DIV1-infected group and negative control group. The x-axis indicates the length of small RNAs, and the y-axis indicates the tag counts. (B) Composition of RNAs in each small RNA library. The x-axis indicates the different samples, and the y-axis indicates the percentage of RNAs. DIV1, decapod iridescent virus 1.
Identification miRNAs and their sequences.
| MiRNA Name | Sequence (5′ –3′) | Length (nt) |
| log2FC |
|---|---|---|---|---|
| miR-10 | ACCCTGTAGATCCGAATTTGT | 21 | 7.45E−03 | 1.37 |
| miR-133-3p_2 | TTGGTCCCCTTCAACCAGCTG | 21 | 5.31E−03 | −0.71 |
| miR-193-3p_6 | TACTGGCCTGCTAAGTCCCAA | 21 | 3.56E−03 | 3.24 |
| miR-210_4 | TTGTGCGTGTGACAGCGGCT | 20 | 2.05E−02 | −0.89 |
| miR-252_3 | CTAAGTAGTAGTGCCGCAGGT | 21 | 1.32E−07 | 7.25 |
| miR-252b_1 | CTAAGTAGTAGTGCCGCAGGTAA | 23 | 4.75E−06 | 6.59 |
| miR-263a-5p_1 | AATGGCACTGGAAGAATTCACGG | 23 | 8.53E−04 | 4.45 |
| miR-263a-5p_2 | AATGGCACTGGAAGAATTCAC | 21 | 2.62E−02 | 3.33 |
| miR-263b | CTTGGCACTGGAAGAATTCACAGA | 24 | 6.90E−05 | 4.90 |
| miR-263b_3 | CTTGGCACTGGAAGAATTCACA | 22 | 5.10E−04 | 4.70 |
| miR-263b-5p_2 | CTTGGCACTGGAAGAATTCAC | 21 | 5.92E−04 | 4.85 |
| miR-2b_4 | TATCACAGCCACCTTTGATGAGC | 23 | 5.31E−03 | −0.48 |
| miR-6489-3p | CGACGGAAAGGTGTCCAAGCTGG | 23 | 8.59E−03 | 2.27 |
| miR-6493-5p | ACGTCCGGCAGGTTTTACCCCT | 22 | 2.13E−04 | 2.21 |
| miR-750_3 | CAGATCTAACTCTTCCAGCTCA | 22 | 3.56E−03 | −3.29 |
| miR-750-3p_3 | CCAGATCTAACTCTTCCAGCTC | 22 | 2.67E−02 | −0.49 |
| miR-79-3p_1 | TAAAGCTAGATTACCAAAGCA | 21 | 1.18E−02 | 0.18 |
| novel_mir24 | TTGTGACCGTTATAATGGGC | 20 | 5.81E−05 | 5.84 |
| novel_mir31 | TAGCACCATGTGAATTCAGTAC | 22 | 2.13E−02 | 2.69 |
| novel_mir34 | TTCGTTGTCGTCGAAACCTGCA | 22 | 5.10E−04 | 4.91 |
| novel_mir40 | ACGCCTTTGGTTTTACGGTCTTCG | 24 | 4.53E−02 | −1.20 |
| novel_mir56 | GGCGGGGGCTGGCGGCGCCGC | 21 | 5.92E−04 | 4.21 |
| novel_mir57 | ATTAGGTTACCGCCGACC | 18 | 3.63E−02 | −4.56 |
| novel_mir58 | TCTCTGCGGCTCTTGGCTCACG | 22 | 3.13E−02 | −1.50 |
| novel_mir60 | TCTCCAGTAGCCTGTTAGGCAT | 22 | 3.73E−04 | −0.43 |
| novel_mir63 | CGCGTGGGGGATGACGGG | 18 | 4.21E−02 | −4.45 |
| novel_mir7 | TTTGGCAGTCGAGTAACTACA | 21 | 2.39E−03 | −0.26 |
| novel_mir73 | GTGGATTCTCTCCCGTTTTC | 20 | 1.99E−07 | 7.53 |
| novel_mir82 | GCGCGGCCGGATGGTGGTG | 19 | 4.21E−02 | −4.44 |
| novel_mir85 | CGTGTTTATATTGTGGGTTTTC | 22 | 2.13E−04 | −0.76 |
| novel_mir86 | GCGCGCGGGCGGCGGTGGCTGC | 22 | 1.96E−10 | 2.50 |
| novel_mir9 | ATTATCATTCTTTGGCGTCCGG | 22 | 4.75E−06 | 1.10 |
Figure 6GO terms and KEGG pathway enrichment analyses of target genes of DEMs. (A) GO term enrichment analysis of target genes of DEMs. Three main GO categories: biological process, cellular component, and molecular function. The x-axis indicates the number of genes, and the y-axis indicates the GO terms (level 2). (B) Top 20 KEGG pathways enriched in target genes of DEMs (level 3). The x-axis indicates the ratio of the number of genes in the DEGs, and the y-axis indicates the pathways. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEMs, differentially expressed miRNAs; DEGs, differentially expressed genes.
Figure 7Validation of RNA-seq results via qRT-PCR. (A) Comparison of the expression profiles of 10 DEGs as determined by Illumina sequencing and qRT-PCR. The x-axis indicates the names of the DEGs, and the y-axis represents the log2(fold change). (B) Comparison of the expression profiles of 8 DEMs as determined by Illumina sequencing and qRT-PCR. The x-axis indicates the names of the DEMs, and the y-axis represents the log2(fold change). DEGs, differentially expressed genes.
Figure 8Network analysis for miRNA/mRNA interaction. (A) MiRNA–mRNA network was formed by 10 upregulated DEMs and 119 downregulated DEGs. (B) MiRNA–mRNA network was formed by 11 downregulated DEMs and 103 upregulated DEGs. Red indicates that genes (miRNAs and mRNAs) were upregulated, and blue represents that genes (miRNAs and mRNAs) were downregulated; the darker the color, the greater the fold change. △ represents miRNA, and ○ represents mRNA. DEGs, differentially expressed genes; DEMs, differentially expressed miRNAs.
Figure 9GO terms and KEGG pathway enrichment analyses of target DEGs of DEMs. (A) GO term enrichment analysis of target DEGs of DEMs. Three main GO categories: biological process, cellular component, and molecular function. The x-axis indicates the number of genes, and the y-axis indicates the GO terms (level 2). (B) Top 20 KEGG pathway enrichment of DEG genes of DEMs (level 3). The x-axis indicates the ratio of the number of genes in the DEGs, and the y-axis indicates the pathways. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes; DEMs, differentially expressed miRNAs.
Figure 10Conceptual diagram of miRNA/mRNA pairs in four potential immune pathways, including the Toll and IMD signaling pathways, Glycosaminoglycan biosynthesis—keratan sulfate, Retinol metabolism, and Ascorbate and aldarate metabolism. Intestinal miRNA can affect the expression of mRNA, thereby regulating apoptosis, AMPs, ROS, keratan sulfate biosynthesis, and VA and VC metabolism, thus resisting DIV1 infection (see the text for detail). Red indicates that genes (miRNAs and mRNAs) were upregulated, and blue indicates that genes (miRNAs and mRNAs) were downregulated. △ represents miRNA, and ○ represents mRNA. AMP, antimicrobial peptide; ROS, reactive oxygen species; VA, vitamin A; VC, vitamin C; DIV1, decapod iridescent virus 1.
Candidate miRNA–mRNA pairs involved in Marsupenaeus japonicus intestinal immune response against DIV1.
| DEM name | Target DEG Name | Homolog Function | Species | MiRNAlog2FC | Targetlog2FC |
|---|---|---|---|---|---|
|
| |||||
| novel_mir40 | CL5325.Contig5_All | Ankyrin-1-like |
| −1.20 | 1.49 |
| novel_mir58 | CL2943.Contig1_All | Transcription factor ATF-2 |
| −1.50 | 1.34 |
| novel_mir60 | CL5043.Contig4_All | Ankyrin-1-like |
| −0.43 | 1.61 |
| novel_mir60 | CL5043.Contig5_All | Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like |
| −0.43 | 1.30 |
| novel_mir73 | CL3555.Contig2_All | Immune deficiency homolog |
| 7.53 | −1.81 |
| novel_mir82 | CL348.Contig1_All | Caspase 4 |
| −4.44 | 1.43 |
| novel_mir86 | CL4844.Contig2_All | Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like isoform X1 |
| 2.50 | −1.10 |
|
| |||||
| miR-6493-5p | Unigene12925_All | Mucin-5AC-like isoform X2 |
| 2.21 | −2.86 |
| miR-750_3 | CL1703.Contig2_All | Uncharacterized protein LOC113809504 |
| −3.29 | 1.24 |
| novel_mir56 | CL2784.Contig3_All | Uncharacterized protein LOC113823076 |
| 4.21 | −5.43 |
| novel_mir56 | CL2784.Contig5_All | Uncharacterized protein LOC113823075 isoform X3 |
| 4.21 | −2.93 |
| novel_mir56 | CL917.Contig2_All | UNC93-like protein MFSD11 |
| 4.21 | −1.89 |
| novel_mir56 | Unigene3462_All | Uncharacterized protein LOC113822805 |
| 4.21 | −1.18 |
| novel_mir58 | Unigene20728_All | Hypothetical protein C7M84_008404 |
| −1.50 | 4.81 |
| novel_mir60 | CL1388.Contig1_All | Hypothetical protein C7M84_016913 |
| −0.43 | 3.13 |
| novel_mir63 | CL1768.Contig3_All | Mucin-5AC-like isoform X2 |
| −4.45 | 1.39 |
| novel_mir63 | CL616.Contig1_All | Uncharacterized protein LOC113812248 |
| −4.45 | 4.15 |
| novel_mir82 | CL2872.Contig1_All | Hypothetical protein C7M84_008734 |
| −4.44 | 1.90 |
| novel_mir82 | CL348.Contig1_All | Caspase 4 |
| −4.44 | 1.43 |
| novel_mir86 | CL5297.Contig3_All | Phospholipase D gamma 3-like |
| 2.50 | −2.50 |
|
| |||||
| novel_mir63 | CL3345.Contig1_All | Mite allergen Der p 3-like |
| −4.45 | 4.32 |
| novel_mir63 | CL3345.Contig2_All | Mite allergen Der p 3-like |
| −4.45 | 5.60 |
|
| |||||
| miR-210_4 | Unigene10280_All | Masquerade-like protein, partial |
| −0.89 | 5.15 |
| novel_mir82 | Unigene18400_All | Copper/zinc superoxide dismutase isoform 5 |
| −4.44 | 1.64 |
| novel_mir82 | Unigene5235_All | Indole-3-acetaldehyde oxidase-like |
| −4.44 | 2.44 |
|
| |||||
| novel_mir58 | CL1549.Contig1_All | Uncharacterized protein LOC113821210 |
| −1.50 | 1.37 |
| novel_mir58 | CL1549.Contig3_All | Uncharacterized protein LOC113821210 |
| −1.50 | 1.75 |
| novel_mir82 | CL348.Contig1_All | Caspase 4 |
| −4.44 | 1.43 |
|
| |||||
| novel_mir56 | CL1568.Contig5_All | Protein draper-like |
| 4.21 | −3.48 |
| novel_mir58 | CL2943.Contig1_All | Transcription factor ATF-2 |
| −1.50 | 1.34 |
| novel_mir58 | CL898.Contig9_All | Dentin sialophosphoprotein-like isoform X3 |
| −1.50 | 4.30 |
| novel_mir86 | CL3368.Contig1_All | Vascular endothelial growth factor receptor precursor |
| 2.50 | −2.11 |
| novel_mir86 | CL3963.Contig1_All | Collagen alpha-1(I) chain-like isoform X2 |
| 2.50 | −2.55 |
|
| |||||
| novel_mir58 | CL1853.Contig1_All | Map kinase-interacting serine/threonine, partial |
| −1.50 | 2.46 |
| novel_mir58 | CL2943.Contig1_All | Transcription factor ATF-2 |
| −1.50 | 1.34 |
| novel_mir86 | CL3368.Contig1_All | Vascular endothelial growth factor receptor precursor |
| 2.50 | −2.11 |
|
| |||||
| miR-133-3p_2 | Unigene896_All | Glucosylceramidase-like |
| −0.71 | 4.21 |
| novel_mir82 | CL1196.Contig2_All | Beta-hexosaminidase subunit alpha-like |
| −4.44 | 3.11 |
|
| |||||
| novel_mir63 | CL1469.Contig5_All | Von Willebrand factor A domain-containing protein 5A-like |
| −4.45 | 1.85 |
| novel_mir82 | CL348.Contig1_All | Caspase 4 |
| −4.44 | 1.43 |
|
| |||||
| novel_mir63 | CL1469.Contig5_All | Von Willebrand factor A domain-containing protein 5A-like |
| −4.45 | 1.85 |
| novel_mir82 | CL348.Contig1_All | Caspase 4 |
| −4.44 | 1.43 |
|
| |||||
| novel_mir82 | CL348.Contig1_All | Caspase 4 |
| −4.44 | 1.43 |
|
| |||||
| novel_mir40 | CL1405.Contig3_All | Leucine-rich repeat extensin-like protein 3 |
| −1.20 | 2.85 |
| novel_mir63 | CL1405.Contig4_All | Leucine-rich repeat extensin-like protein 3 |
| −4.45 | 4.03 |
| novel_mir56 | CL1610.Contig1_All | Paxillin-like |
| 4.21 | −4.61 |
| novel_mir82 | CL3064.Contig1_All | Basic proline-rich protein-like, partial |
| −4.44 | 1.70 |
|
| |||||
| novel_mir40 | CL1405.Contig3_All | Leucine-rich repeat extensin-like protein 3 |
| −1.20 | 2.85 |
| novel_mir56 | CL4657.Contig5_All | Receptor-type tyrosine-protein phosphatase delta-like |
| 4.21 | −1.28 |
| novel_mir63 | CL1405.Contig4_All | Leucine-rich repeat extensin-like protein 3 |
| −4.45 | 4.03 |
| novel_mir82 | CL3064.Contig1_All | Basic proline-rich protein-like, partial |
| −4.44 | 1.70 |
|
| |||||
| novel_mir82 | CL348.Contig1_All | Caspase 4 |
| −4.44 | 1.43 |
|
| |||||
| novel_mir63 | CL1418.Contig2_All | UDP-glucuronosyltransferase |
| −4.45 | 2.75 |
| novel_mir63 | CL1418.Contig3_All | UDP-glucuronosyltransferase |
| −4.45 | 3.05 |
| novel_mir63 | CL1418.Contig6_All | UDP-glucuronosyltransferase |
| −4.45 | 3.41 |
|
| |||||
| novel_mir63 | CL1418.Contig2_All | UDP-glucuronosyltransferase |
| −4.45 | 2.75 |
| novel_mir63 | CL1418.Contig3_All | UDP-glucuronosyltransferase |
| −4.45 | 3.05 |
| novel_mir63 | CL1418.Contig6_All | UDP-glucuronosyltransferase |
| −4.45 | 3.41 |
|
| |||||
| novel_mir63 | CL427.Contig1_All | Alpha-(1,6)-fucosyltransferase-like |
| −4.45 | 6.87 |
| novel_mir63 | CL427.Contig9_All | Alpha-(1,6)-fucosyltransferase-like |
| −4.45 | 3.37 |
|
| |||||
| novel_mir82 | Unigene17220_All | Hypothetical protein C7M84_016157 |
| −4.44 | 3.71 |
|
| |||||
| novel_mir82 | Unigene17220_All | Hypothetical protein C7M84_016157 |
| −4.44 | 3.71 |
|
| |||||
| novel_mir82 | CL1196.Contig2_All | Beta-hexosaminidase subunit alpha-like |
| −4.44 | 3.11 |
|
| |||||
| novel_mir82 | CL1196.Contig2_All | Beta-hexosaminidase subunit alpha-like |
| −4.44 | 3.11 |
DIV1, decapod iridescent virus 1.